Cite
MLA Citation
Morven Wilkie et al.. “A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime – MVA85A boost in healthy UK adults.” Vaccine, vol. 38, no. 4, 2020, pp. 779–789. http://access.bl.uk/ark:/81055/vdc_100098799139.0x000037